Phase III China GT 1b Interferon (IFN) Intolerant Prev Exclude Dual
Clinical trial NCT01995266 · COMPLETED
Trial details
- NCT number
- NCT01995266
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-28
- Primary completion
- 2015-07-31
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.